Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeon Corp
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Nippon Zeon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd, Nippon Zeon Co LtdfiledCriticalTaisho Pharmaceutical Co Ltd
Priority to JP59249760ApriorityCriticalpatent/JPS61129176A/ja
Publication of JPS61129176ApublicationCriticalpatent/JPS61129176A/ja
Publication of JPH0546342B2publicationCriticalpatent/JPH0546342B2/ja
Process for the separation of 2,4-dinitro-6-t-butyl-3-methylanisole, referred to as musk ambrette, from the crude synthesis mixtures in which it is present